Previous 10 | Next 10 |
2024-06-23 20:39:26 ET Summary Harris Associates' 13F portfolio value increased from $58.03B to $61.82B this quarter, with around 200 positions reported. The top five stakes in the portfolio are Alphabet, IQVIA, Capital One Financial, Fiserv, and Intercontinental Exchange, totalin...
2024-06-22 14:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-20 10:50:09 ET More on iShares Russell 1000 Growth ETF: IWF: It Worked Well, But Is Vulnerable Going Forward Stocks with the highest swings in option premium price over 3 months - JPM Stocks with the least price swings, most attractive option-sale candidates ...
2024-06-12 15:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Bold initiative to boost the capacity of research sites enters Beta testing and piloting IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for the key systems and tasks a clinical res...
Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a potential increase of more than 12 million new annual cases Global spending on cancer medicine increased to $223 billion in 2023, $25 billion mo...
2024-06-06 06:00:06 ET Matthew Sykes from Goldman Sachs issued a price target of $270.00 for IQV on 2024-06-06 04:43:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $218.9. The overall price target consensus is at $27...
2024-06-04 16:12:36 ET Summary Medpace Holdings is a US-based clinical research organization that is well-positioned to benefit from increased demand due to geopolitical risks affecting Chinese firms. Medpace stands out among its peers due to its growth orientation, competitive ma...
2024-06-03 14:46:53 ET More on Consumer Staples Select Sector SPDR ETF, Health Care Select Sector SPDR, etc. Read the full article on Seeking Alpha For further details see: Sell ideas in Staples and Health Care - Oppenheimer
2024-05-28 13:17:59 ET Summary IQVIA provides a broad range of services to biopharma customers, including outsourced R&D services in support of clinical trials. Recent spending caution and the end of COVID-related revenue have led to modest headwinds. AI-enabled drug disco...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $3,814 million GAAP Net Income of $363 million, Adjusted EBITDA of $887 million GAAP Diluted Earnings per Share of $1.97, Adjusted Diluted Earnings per Share of $2.64 R&D Solutions quarterly bookings of $2.7 billion, representing a book-to-bill ratio of 1.27...
IQVIA ™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiven...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release ...